Atiq, M. O., Stadler, W. M., Page, A., Catenacci, M., Patnaik, A., Paner, G. P., Eggener, S., Szmulewitz, R. Z. (2025). Neoadjuvant androgen deprivation therapy with enzalutamide plus the glucocorticoid receptor modulator relacorilant versus placebo for patients with high-risk localized prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps436